Cargando…
Sustained Release of MiR-217 Inhibitor by Nanoparticles Facilitates MSC-Mediated Attenuation of Neointimal Hyperplasia After Vascular Injury
Mesenchymal stem cells (MSCs) have been proven capable of differentiating into endothelial cells (ECs) and increasing vascular density in mouse ischemia models. However, the therapeutic potential of MSCs in neointimal hyperplasia after vascular injury is still not fully understood. In this study, we...
Autores principales: | Yu, Hong, Hua, Yutao, He, Yecheng, Wang, Yin, Hu, Xingjian, Chen, Si, Liu, Junwei, Yang, Junjie, Li, Huadong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542691/ https://www.ncbi.nlm.nih.gov/pubmed/34708092 http://dx.doi.org/10.3389/fcvm.2021.739107 |
Ejemplares similares
-
Anemoside B4 Inhibits Vascular Smooth Muscle Cell Proliferation, Migration, and Neointimal Hyperplasia
por: Shan, Dan, et al.
Publicado: (2022) -
Single-Cell RNA Sequencing of the Rat Carotid Arteries Uncovers Potential Cellular Targets of Neointimal Hyperplasia
por: Gao, Xiao-Fei, et al.
Publicado: (2021) -
Covalent modification of pericardial patches for sustained rapamycin delivery inhibits venous neointimal hyperplasia
por: Bai, Hualong, et al.
Publicado: (2017) -
Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts
por: Zou, Junjie, et al.
Publicado: (2011) -
Vinpocetine Attenuates Neointimal Hyperplasia in Diabetic Rat Carotid Arteries after Balloon Injury
por: Wang, Ke, et al.
Publicado: (2014)